Shenzhen Hepalink Pharmaceutical : NOTICE OF THE 2020 ANNUAL GENERAL MEETING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.

( 深圳市海普瑞藥業集團股份有限公司 )

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 9989)

NOTICE OF THE 2020 ANNUAL GENERAL MEETING

NOTICE IS HEREBY GIVEN that the 2020 annual general meeting (the "AGM") of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (the "Company") will be held at 2:30 p.m. on Wednesday, May 26, 2021 at Ballroom, 2/F, L'Hermitage Hotel, 3031 Nanhai Boulevard, Nanshan District, Shenzhen, the PRC for the purpose of considering, and if thought fit, passing the following resolutions. Unless otherwise indicated, capitalized terms used herein shall have the same meanings as defined in the circular of the Company dated April 23, 2021.

ORDINARY RESOLUTIONS

To consider and pass the following ordinary resolutions by way of non-cumulative voting:

1. The resolution regarding the 2020 Work Report of the Board of Directors of the Company;
2. The resolution regarding the 2020 Work Report of the Board of Supervisors of the Company;
3. The resolution regarding the 2020 Annual Report and its Summary, H Share Results Announcement, H Shares 2020 Annual Report, 2020 Corporate Governance Report and 2020 Environmental, Social and Governance Report of the Company;
4. The resolution regarding the 2020 Final Financial Report of the Company;
5. The resolution regarding the 2020 Profit Distribution Proposal of the Company;
6. The resolution regarding the re-appointment of auditors of the Company;

1

SPECIAL RESOLUTIONS

To consider and pass the following special resolutions by way of non-cumulative voting:

1. The resolution regarding the 2021-2023 Shareholder Return Three-Year Plan of the Company;
2. The resolution regarding the application for credit line and providing guarantee to certain banks for 2021 of the Company;
3. The resolution regarding the purchase of wealth management products and cash flow management using part of the unemployed H Shares IPO Proceeds of the Company; and

ORDINARY RESOLUTION

To consider and pass the following ordinary resolution by way of non-cumulative voting:

10. The resolution regarding the appointment of executive director of the Company.

By order of the Board

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Li Li

Chairman

Shenzhen, PRC

April 23, 2021

Notes:

1. The register of members of the Company's H shares will be closed from May 21, 2021 to May 26, 2021 (both days inclusive), during which period no transfer of H shares can be registered. In order for H share shareholders to be qualified to attend and vote at the AGM, all transfer documents accompanied by the relevant share certificates must be lodged with the H Shares registrar of the Company, Tricor Investor Services Limited, at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong, no later than 4:30 p.m. on May 20, 2021 for registration.
   The H share shareholders whose names appear on the register of members of the Company's H shares on May 21, 2021 are entitled to attend and vote at the AGM.
2. H share shareholders who are entitled to attend and vote at the AGM may appoint one or more proxies to attend and vote on their behalves. A proxy need not be a shareholder.
3. The instrument appointing a proxy must be in writing under the hand of a shareholder or his attorney duly authorised in writing. If the shareholder is a legal person, that instrument must be executed either under its seal or under the hand of its director or other attorney duly authorised to sign the same on its behalf.
4. In order to be valid, the proxy form must be deposited, for H share shareholders, to the H Shares registrar of the Company, Tricor Investor Services Limited at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong not less than 24 hours before the time for holding the AGM. If the proxy form is signed by a person under a power of attorney or other authority, a notarized copy of that power of attorney or other authority shall be deposited at the same time as mentioned in the proxy form. Completion and return of the proxy form will not preclude the shareholders from attending and voting in person at the AGM or any adjourned meetings should they so wish.

2

1. Shareholders shall produce their identification documents and supporting documents in respect of the shares of the Company held when attending the AGM. If corporate shareholders appoint authorised representative to attend the AGM, the authorised representative shall produce his/her identification documents and a notarized copy of the relevant authorisation instrument signed by the board of directors or other authorised parties of the corporate shareholders or other notarized documents allowed by the Company. Proxies shall produce their identification documents and the proxy form signed by the shareholders or their attorney when attending the AGM.
2. The AGM is expected to take for less than half a day. Shareholders attending the AGM shall be responsible for their own travel and accommodation expenses.
3. All voting at the AGM will be conducted by poll.
4. References to times and dates of this notice are to Hong Kong times and dates.

As at the date of this announcement, the executive directors of the Company are Mr. Li Li, Ms. Li Tan, Mr. Shan Yu and Mr. Sun Xuan; and the independent non-executive directors of the Company are Dr. Lu Chuan, Mr. Chen Junfa and Mr. Wang Zhaohui.

3